Limbix (by BigHealth)
Evidence-based digital therapeutics for adolescent mental health and behavioral activation.
AI-driven chronic condition management via real-time data signals and personalized coaching.
Livongo, a subsidiary of Teladoc Health, is a market-leading digital health platform that utilizes an 'Applied Health Signals' engine to manage chronic conditions such as diabetes, hypertension, and weight management. By 2026, the platform has evolved from a simple remote monitoring tool into a sophisticated AI-first ecosystem. Its architecture relies on cellular-connected hardware (glucometers and blood pressure cuffs) that bypasses traditional Bluetooth pairing issues to provide instantaneous data transmission to the cloud. The platform's proprietary AI models analyze these data points against historical clinical benchmarks to deliver 'Health Nudges'—real-time, actionable insights sent to the user's device. For enterprises and health plans, Livongo provides a scalable solution to reduce medical spend by preventing acute health episodes through predictive modeling. The technical stack integrates deeply with EMR (Electronic Medical Record) systems and utilizes high-fidelity NLP for its virtual coaching components, positioning it as a cornerstone of the 'Whole Person Care' strategy in the digital health sector.
Devices utilize built-in cellular chips to transmit data directly to the cloud, eliminating the need for smartphone pairing or Wi-Fi configuration.
Evidence-based digital therapeutics for adolescent mental health and behavioral activation.
Scaleable AI-driven chronic disease management and prevention through conversational coaching.
AI-driven primary care platform revolutionizing patient triage and digital health delivery.
FDA-cleared digital therapeutics leveraging AI-driven neuro-gaming to treat cognitive dysfunction.
Verified feedback from the global deployment network.
Post queries, share implementation strategies, and help other users.
A proprietary AI layer that processes millions of data points to identify patterns and predict hypoglycemic or hypertensive events before they occur.
Context-aware notifications delivered within 2 minutes of a reading, utilizing NLP to provide relevant clinical guidance.
Advanced tracking for users on GLP-1 medications, monitoring side effects and muscle mass retention via smart scale data.
Direct API integration with Continuous Glucose Monitors (CGM) for real-time streaming of interstitial fluid glucose levels.
The platform tracks strip usage via the connected meter and triggers an automated fulfillment order when supply drops below a threshold.
When the AI detects a dangerously high or low reading, it triggers an immediate outreach protocol for a live Certified Diabetes Care and Education Specialist (CDCES).
A user's glucose drops significantly during the night.
Registry Updated:2/7/2026
Consistently high blood pressure readings without the user noticing a trend.
High ER visit costs due to uncontrolled diabetes.